Literature DB >> 6723073

Urine and faecal porphyrin profiles by reversed-phase high-performance liquid chromatography in the porphyrias.

C K Lim, T J Peters.   

Abstract

A novel reversed-phase system is described for the simultaneous separation of type I and type III isomers of uro-, heptacarboxylic-, hexacarboxylic -, pentacarboxylic - and copro -porphyrins and the dicarboxylic meso- and proto-porphyrins. The porphyrins were resolved on a Hypersil -SAS column eluted with 10% (v/v) acetonitrile in 1 mol/l ammonium acetate, pH 5.16 (solvent A) and 10% (v/v) acetonitrile in methanol (solvent B) with a linear gradient from 100% A (0%B) to 35% A (65%B) in 30 min followed by isocratic elution at 65% B for a further 10 min. The method is simple and reproducible and has been applied to the analysis of porphyrins in urine and faeces from patients with acute intermittent, variegate, hereditary copro , congenital erythropoietic, erythrohepatic proto and symptomatic porphyrias.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6723073     DOI: 10.1016/0009-8981(84)90192-x

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  27 in total

Review 1.  Review: porphyrins as biomarkers for hazard assessment of bird populations: destructive and non-destructive use.

Authors:  Silvia Casini; M Cristina Fossi; Claudio Leonzio; Aristeo Renzoni
Journal:  Ecotoxicology       Date:  2003 Feb-Aug       Impact factor: 2.823

2.  Pro-oxidant and antioxidant factors in acute intermittent porphyria: family studies.

Authors:  E Rocchi; P Ventura; A Ronzoni; M C Rosa; C Gozzi; L Marri; G Casalgrandi; M D Cappellini
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

Review 3.  Porphyrias at a glance: diagnosis and treatment.

Authors:  Maria Domenica Cappellini; Valentina Brancaleoni; Giovanna Graziadei; Dario Tavazzi; Elena Di Pierro
Journal:  Intern Emerg Med       Date:  2010-10       Impact factor: 3.397

4.  Hereditary coproporphyria: comparison of molecular and biochemical investigations in a large family.

Authors:  K R Allen; S D Whatley; T J Degg; J H Barth
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

5.  Hemolytic anemia repressed hepcidin level without hepatocyte iron overload: lesson from Günther disease model.

Authors:  Sarah Millot; Constance Delaby; Boualem Moulouel; Thibaud Lefebvre; Nathalie Pilard; Nicolas Ducrot; Cécile Ged; Philippe Lettéron; Lucia de Franceschi; Jean Charles Deybach; Carole Beaumont; Laurent Gouya; Hubert De Verneuil; Saïd Lyoumi; Hervé Puy; Zoubida Karim
Journal:  Haematologica       Date:  2016-11-10       Impact factor: 9.941

6.  Cystathionine-γ-lyase (CSE) deficiency increases erythropoiesis and promotes mitochondrial electron transport via the upregulation of coproporphyrinogen III oxidase and consequent stimulation of heme biosynthesis.

Authors:  Katalin Módis; V-M Sadagopa Ramanujam; Armita Abdollahi Govar; Ernesto Lopez; Karl E Anderson; Rui Wang; Csaba Szabo
Journal:  Biochem Pharmacol       Date:  2019-08-14       Impact factor: 5.858

7.  Genetic and biochemical characterization of 16 acute intermittent porphyria cases with a high prevalence of the R173W mutation.

Authors:  J To-Figueras; C Badenas; C Carrera; C Muñoz; M Milá; M Lecha; C Herrero
Journal:  J Inherit Metab Dis       Date:  2006-08       Impact factor: 4.982

8.  The effect of blue light on periodontal biofilm growth in vitro.

Authors:  Carla R Fontana; Xiaoqing Song; Angeliki Polymeri; J Max Goodson; Xiaoshan Wang; Nikolaos S Soukos
Journal:  Lasers Med Sci       Date:  2015-03-11       Impact factor: 3.161

9.  High-performance liquid chromatography of uroporphyrinogen and coproporphyrinogen isomers with amperometric detection.

Authors:  C K Lim; F Li; T J Peters
Journal:  Biochem J       Date:  1986-03-15       Impact factor: 3.857

10.  In situ conversion of coproporphyrinogen to heme by murine mitochondria: terminal steps of the heme biosynthetic pathway.

Authors:  K L Proulx; S I Woodard; H A Dailey
Journal:  Protein Sci       Date:  1993-07       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.